Antisense protein kinase A RIα-induced tumor reversion: portrait of a microarray
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1697 (1-2) , 71-79
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Antisense and sensibilityNature Biotechnology, 2002
- Antisense therapy in oncology: new hope for an old idea?The Lancet, 2001
- Oligonucleotide technologies: synthesis, production, regulations and applicationsExpert Opinion on Biological Therapy, 2001
- Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinicExpert Opinion on Therapeutic Patents, 2000
- Oligonucleotide Therapeutics: A Step ForwardJournal of Clinical Oncology, 2000
- Antisense oligonucleotides: Is the glass half full or half empty?Biochemical Pharmacology, 1998
- In vivo studies with antisense oligonucleotidesTrends in Pharmacological Sciences, 1997
- Antisense oligonucleotides: towards clinical trialsTrends in Biotechnology, 1996
- A single-injection protein kinase A-directed antisense treatment to inhibit tumour growthNature Medicine, 1995
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proceedings of the National Academy of Sciences, 1978